Editorial Commentary: Platelet-Rich Plasma and Knee Meniscal Repair-The Use of Biologics Has Not Progressed Substantially Since 1983.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32503782.
- Also identified by DOI 10.1016/j.arthro.2020.04.006.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
When it comes to meniscal repair, optimizing the local biological environment at the repair site by performing trephination to create bleeding from the extracapsular capillary network, by rasping to abrade the local synovial tissue, or by creating bleeding from the intercondylar notch is recommended. The addition of platelet-rich plasma probably also helps, especially absent the bleeding when meniscal repair is performed concomitantly with anterior cruciate ligament reconstruction. However, pending future research, there is not enough data to recommend platelet-rich plasma augmentation for meniscal repair in all cases.
Medical subject headings
- Anterior Cruciate Ligament Injuries
- Biological Products
- Knee Injuries
- Platelet-Rich Plasma
- Tibial Meniscus Injuries
Anatomy
- knee
- tibia